In 2023, the mortality rate for stomach malignant neoplasms in Japan stood at 32.2 deaths per hundred thousand people. The forecasted data from 2024 to 2028 shows a gradual decline in this rate. Specifically, the mortality rate is expected to decrease from 32.0 in 2024 to 31.0 by 2028.

Year-on-year variations indicate an average annual decrease of approximately 0.35%. Over the last two years, this reflects a consistent reduction trend, enhancing the effectiveness of medical interventions and potentially early detection strategies in Japan.

Future trends to watch for include:

Advancements in medical technology and treatment methods.
Public health campaigns aimed at early detection and prevention.
Potential impacts of demographic changes, such as an aging population, on health resource allocation.